| Net Cash Provided by (Used in) Operating Activities |
$50,194,000 |
USD |
36% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$60,513,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
37,954,364 |
shares |
12% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$10,319,000 |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$79,606,000 |
USD |
39% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$8,394,000 |
USD |
6.7% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$641,376,000 |
USD |
13% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$28,844,000 |
USD |
29% |
Q4 2025 |
FY 2025 |